Clarus Ventures
101 Main Street
Suite 1210
Cambridge
Massachusetts
02142
United States
Tel: 617-949-2200
Fax: 617-949-2201
Website: https://www.clarusfunds.com/
About Clarus Ventures
11 articles about Clarus Ventures
-
Lycera Announces Publication of Preclinical Immuno-Oncology Research
5/16/2018
Lycera Corp., a privately held biopharmaceutical company developing breakthrough immune modulatory medicines, today announced the publication of new preclinical research findings describing the potential utility of the Company's most advanced cancer immunotherapy platform, selective RORgamma agonists, in adoptive cell therapy applications.
-
Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund
7/18/2017
-
Clarus Ventures Promotes Dr. Emmett Cunningham To Managing Director, Dr. Barry Gertz To Partner, And Dr. Ari Brettman To Principal
1/6/2017
-
Clarus Ventures Adds Kiran Reddy, Robert DeBenedetto, And Lazar Dimitrov To Investment Team
1/7/2016
-
Life Science Firms Froth as VC Firm Clarus Ventures Nabs Another $500 Million
6/10/2015
-
Clarus Ventures Promotes Michele Park, Ph.D., To Partner
5/18/2015
-
Clarus Ventures Promotes Scott Requadt To Managing Director
1/6/2015
-
Clarus Ventures Adds Barry Gertz, M.D., Ph.D., And Ari Brettman, M.D., To Cambridge Office
10/27/2014
-
Life Sciences VC Firm, Clarus Ventures Eyes $375 Million
2/7/2014
-
Clarus Ventures Names William D. Young Venture Partner
3/23/2010
-
Clarus Ventures Closes $660 Million Fund
2/25/2008